← Open Payments lookup

MARJORIE CARO: Open Payments

NPI 1902811490 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,237 in 40 payments from 10 companies in 2025. Trend: 2023 $1,009 · 2024 $986 · 2025 $1,237

Food & beverage: $1,127Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.19$498
Eisai Inc.4$205
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$164
Otsuka America Pharmaceutical, Inc.8$162
Boehringer Ingelheim Pharmaceuticals, Inc.1$88
Neurocrine BioSciences, Inc.1$34
Biogen, Inc.1$29
E.R. Squibb & Sons, L.L.C.1$22
Lundbeck LLC1$20
TMS NeuroHealth Centers Inc.1$13

Products named: AUSTEDO XR, LEQEMBI, CAPLYTA, JARDIANCE, ABILIFY ASIMTUFII, ABILIFY MAINTENA, REXULTI, INGREZZA.

Industry payments across FL — which companies pay providers there.